Navigation path

Themes
Agriculture & food
Energy
Environment
ERA-NET
Health & life sciences
Human resources & mobility
Industrial research
  Building & construction
  Coal & steel
  Industrial processes & robotics
  Materials & products
  Nanotechnology
  Standards, measures & testing
  Other
Information society
Innovation
International cooperation
Nanotechnology
Pure sciences
Research infrastructures
Research policy
Science & business
Science in society
Security
SMEs
Social sciences and humanities
Space
Special Collections
Transport

Countries
Countries
  Argentina
  Australia
  Austria
  Belarus
  Belgium
  Benin
  Botswana
  Brazil
  Bulgaria
  Cameroon
  Canada
  Chile
  China
  Colombia
  Croatia
  Cyprus
  Czech Republic
  Denmark
  Egypt
  Estonia
  Finland
  France
  Georgia
  Germany
  Ghana
  Greece
  Hungary
  Iceland
  India
  Ireland
  Israel
  Italy
  Japan
  Kazakhstan
  Kenya
  Korea
  Latvia
  Lichtenstein
  Lithuania
  Luxembourg
  Madagascar
  Malta
  Mexico
  Montenegro
  Morocco
  Namibia
  Netherlands
  Nigeria
  Norway
  Peru
  Poland
  Portugal
  Romania
  Russia
  Senegal
  Serbia
  Slovakia
  Slovenia
  South Africa
  Spain
  Sri Lanka
  Swaziland
  Sweden
  Switzerland
  Taiwan
  Tanzania
  Tunisia
  Turkey
  Uganda
  Ukraine
  United Kingdom
  United States


This page was published on 15/05/2007
Published: 15/05/2007

   Industrial research

Last Update: 15-05-2007  
Related category(ies):
Health & life sciences  |  Industrial research  |  Science in society

 

Add to PDF "basket"

Giving patients a heads up on genetic disease and testing

Advances in genetic testing, which analyse the blood or body tissues of patients, have bolstered doctors' abilities to diagnose and treat several illnesses. But EuroGentest went one step further and not only conducted a major survey examining the quality of existing patient information in the EU, but it has published a series of 11 patient information leaflets on the main topics in genetic disease and genetic testing. Supported by patient information groups, the leaflets are available in English and are currently being translated into Italian, Polish and Romanian. They will eventually be translated into all the main EU languages.

The patient information leaflets on genetic testing will be available in all main EU languages. © EuroGentest
The patient information leaflets on genetic testing will be available in all main EU languages.
© EuroGentest
The leaflets will be made available for all concerned Europeans at EU-based genetic clinics, patient groups and other key organisations. Celine Lewis, project researcher, said the team found major differences in the prevailing situations, both between and within the seven nations initially surveyed.

‘In some cases, a combination of patient letters and pre-written leaflets were provided to patients and families during the genetic consultation, in others one or the other,’ explained Lewis. ‘However, no country had a comprehensive or standardised approach.’

According to Lewis, the researchers determined that there were major differences in the quality of written information in genetic clinics that patients had access to. ‘Whilst the majority of the material we assessed provided information about the condition being tested for, less than a quarter provided information on the psychological and social consequences of genetic testing, and only half provided details concerning where to access additional information and support,’ she remarked.

The researchers asked patient interest groups what their views were on the information available to people. Lewis noted that they all voiced a common concern; despite the fact that the benefits of genetic tests were usually covered, the ‘risks were either not adequately explained’ or not dealt with at all the groups had said.

‘This was also one of the major findings during the assessment. Another major finding was that pre-written materials were far more comprehensive in discussing the key issues than personal letters were, and this was the impetus for developing pre-written information leaflets for use across the EU,’ she commented.

Lewis said that the team used the resources of the EuroGentest network and conferred with all major stakeholders to develop ‘a series of 11 leaflets for patients and families about Genetic Inheritance Patterns, Chromosome Problems, Genetic Testing and Information about Your Genetic Appointment.’

She also referred to a 'Frequently Asked Questions' leaflet and 'Genetic Glossary' that patients and families, who will speak to a specialist about genetic testing, can use. ‘This information is designed to be used alongside the discussions patients and families have with a genetic specialist,’ Lewis said.

Convert article(s) to PDF

No article selected


loading


Search articles

Notes:
To restrict search results to articles in the Information Centre, i.e. this site, use this search box rather than the one at the top of the page.

After searching, you can expand the results to include the whole Research and Innovation web site, or another section of it, or all Europa, afterwards without searching again.

Please note that new content may take a few days to be indexed by the search engine and therefore to appear in the results.

Print Version
Share this article
See also

EuroGentest
Headlines, 27 Dec. 2006: EU Network setting the standard for genetic testing





  Top   Research Information Center